Investigation of phase SPR biosensor for efficient targeted drug screening with high sensitivity and stability

All-fiber SPR microfluidic chip for GDF11 detection

In order to perform microfluidic detection of cytokines with low concentration, such as growth differentiation factor 11 (GDF11), the most common method is to construct microfluidic channels and integrate them with SPR sensing units. In this paper, we proposed a novel all-fiber SPR microfluidic chip for GDF11 detection. The method was to construct the SPR sensing area on a designed D-shaped multimode fiber, which was nested inside a quartz tube to form a semi-cylindrical microfluidic channel. The surface of the SPR sensing area experienced sensitization and specifically modification to achieve the specific detection of GDF11. When the sensitivity of detection was 1.38 nm/lg(g/mL) and the limit of detection was 0.52 pg/mL, the sample consumption was only 0.4 µL for a single detection. The novel all-fiber SPR microfluidic detection chip has the advantages of flexible design, compact structure and low sample consumption, which is expected to be used in wearable biosensing devices for real-time online monitoring of trace cytokines in vivo.

Properties and Applications of Graphene and Its Derivatives in Biosensors for Cancer Detection: A Comprehensive Review

Cancer is one of the deadliest diseases worldwide, and there is a critical need for diagnostic platforms for applications in early cancer detection. The diagnosis of cancer can be made by identifying abnormal cell characteristics such as functional changes, a number of vital proteins in the body, abnormal genetic mutations and structural changes, and so on. Identifying biomarker candidates such as DNA, RNA, mRNA, aptamers, metabolomic biomolecules, enzymes, and proteins is one of the most important challenges. In order to eliminate such challenges, emerging biomarkers can be identified by designing a suitable biosensor. One of the most powerful technologies in development is biosensor technology based on nanostructures. Recently, graphene and its derivatives have been used for diverse diagnostic and therapeutic approaches. Graphene-based biosensors have exhibited significant performance with excellent sensitivity, selectivity, stability, and a wide detection range. In this review, the principle of technology, advances, and challenges in graphene-based biosensors such as field-effect transistors (FET), fluorescence sensors, SPR biosensors, and electrochemical biosensors to detect different cancer cells is systematically discussed. Additionally, we provide an outlook on the properties, applications, and challenges of graphene and its derivatives, such as Graphene Oxide (GO), Reduced Graphene Oxide (RGO), and Graphene Quantum Dots (GQDs), in early cancer detection by nanobiosensors.

Interferon-γ detection in point of care diagnostics: Short review

Interferon (IFN)-γ is a cytokine secreted by immune cells. The elevated levels of IFN-γ are an early indicator of multiple diseases such as tuberculosis and autoimmune diseases. This short review focuses on different sensing methods based on optical, electrochemical, and mechanical principles. We explain how specific biorecognition molecules such as antibodies and aptamers are employed in the sensing methods. We also compare different surface functionalization methods and their details. Although the review gives an overview of only IFN-γ sensing, the same strategies can be applied to sensing other analytes with appropriate modifications.

Gold-silver alloy film based surface plasmon resonance sensor for biomarker detection

In this study, we developed a gold‑silver alloy film based surface plasmon resonance (AuAg-SPR) sensor with wavelength interrogation to detect cancer antigen 125 (CA125) using a sandwich immunoassay. We first theoretically simulated the sensitivity of conventional gold film based SPR (Au-SPR) sensor and AuAg-SPR sensor, and conducted a series of experiments to investigate the sensitive characteristics of AuAg-SPR sensor, including the angle and refractive index (RI) sensitivity. We then conducted CA125 detection experiments on these two types of sensors. The results demonstrated that the limit of detection (LOD) of CA125 on the AuAg-SPR sensor was 0.1 U/mL (0.8 ng/mL) based on its direct reaction with an immobilised antibody, which was two orders of magnitude lower than that of the Au-SPR sensor (10 U/mL). The total changes in the resonance wavelength (∆λ_R) of the former were 1.7-fold those of the latter. The volume fractions of the adsorbates (f_ad) and effective RIs (n_adlayer) in each adlayer were then calculated and the effect of the antibody size on the detection results was analysed. The AuAg-SPR sensors had a higher sensitivity than the conventional Au-SPR sensors for detecting CA125 due to their electric field characteristics. Therefore, these will have better application prospects.

Recent Progress in Optical Sensors for Biomedical Diagnostics

In recent years, several types of optical sensors have been probed for their aptitude in healthcare biosensing, making their applications in biomedical diagnostics a rapidly evolving subject. Optical sensors show versatility amongst different receptor types and even permit the integration of different detection mechanisms. Such conjugated sensing platforms facilitate the exploitation of their neoteric synergistic characteristics for sensor fabrication. This paper covers nearly 250 research articles since 2016 representing the emerging interest in rapid, reproducible and ultrasensitive assays in clinical analysis. Therefore, we present an elaborate review of biomedical diagnostics with the help of optical sensors working on varied principles such as surface plasmon resonance, localised surface plasmon resonance, evanescent wave fluorescence, bioluminescence and several others. These sensors are capable of investigating toxins, proteins, pathogens, disease biomarkers and whole cells in varied sensing media ranging from water to buffer to more complex environments such as serum, blood or urine. Hence, the recent trends discussed in this review hold enormous potential for the widespread use of optical sensors in early-stage disease prediction and point-of-care testing devices.

Covalent affixation of histidine-tagged proteins tethered onto Ni-nitrilotriacetic acid sensors for enhanced surface plasmon resonance detection of small molecule drugs and kinetic studies of antibody/antigen interactions

Covalent affixation of histidine-tagged proteins tethered onto Ni-nitrilotriacetic acid sensors for enhanced surface plasmon resonance detection.

Phase-sensitivity-doubled surface plasmon resonance sensing via self-mixing interference

Conventional phase-based surface plasmon resonance (SPR) sensing can achieve 10^-8  RIU, but commonly requires two-beam interference. It therefore leads to complexity in terms of utilized devices, poor anti-noise ability, and demand for fine working conditions. With these requirements imposed, conventional SPR sensing has difficulties in commercial use. In this Letter, we report a simple, compact, and phase-sensitivity-doubled self-mixing interference (SMI)-based SPR sensing approach. The reported approach employs SMI and, therefore, needs only one optical path, enabling the advantages of compactness and simplicity in experimental setup, and strong anti-vibration property. With the proposed setup, the phase of light from the prism to the sample changes twice. Consequently, the sensitivity of phase is doubled. For experimental demonstration, we monitor the refractive index change of NaCl solution by using the proposed technique. The experimental results coincide with the theoretical analysis and simulation results.

Investigation of an SPR biosensor for determining the influence of connexin 43 expression on the cytotoxicity of cisplatin

The real-time and label free detection abilities of surface plasmon resonance (SPR) biosensors provide a way of evaluating the influence of some genes’ expression on anti-tumor drug cytotoxicity.